Point Of Care Infectious Disease Market Size, Share, Industry Trends and Forecast to 2033
This report provides an extensive analysis of the Point Of Care Infectious Disease market, covering insights into market size, trends, and forecasts from 2023 to 2033, with a focus on regional performance and technological advancements.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $7.50 Billion |
| CAGR (2023-2033) | 9.7% |
| 2033 Market Size | $19.56 Billion |
| Top Companies | Roche Diagnostics, Abbott Laboratories, Siemens Healthineers |
| Last Modified Date | 15 Nov 2024 |
Point Of Care Infectious Disease Market Report (2023 - 2033)
Point Of Care Infectious Disease Market Overview
What is the Market Size & CAGR of Point Of Care Infectious Disease market in 2023 and 2033?
Point Of Care Infectious Disease Industry Analysis
Point Of Care Infectious Disease Market Segmentation and Scope
Request a custom research report for industry.
Point Of Care Infectious Disease Market Analysis Report by Region
Europe Point Of Care Infectious Disease Market Report:
Europe is projected to show significant growth in the POC infectious disease market, rising from $2.27 billion in 2023 to $5.91 billion by 2033. The region's focus on decentralized healthcare and the adoption of innovative technologies will support this growth.Asia Pacific Point Of Care Infectious Disease Market Report:
The Asia Pacific region is expected to experience substantial growth, reflecting an increase from $1.53 billion in 2023 to $3.99 billion by 2033. The rising prevalence of infectious diseases, along with rapid urbanization and improving healthcare infrastructure, are key drivers.North America Point Of Care Infectious Disease Market Report:
In North America, the market size will expand from $2.56 billion in 2023 to $6.67 billion by 2033, fueled by advanced healthcare facilities, increasing investments in POC technologies, and a higher incidence of infectious diseases.South America Point Of Care Infectious Disease Market Report:
The South American market is anticipated to grow from $0.46 billion in 2023 to $1.19 billion by 2033. The increased focus on improving healthcare access and the need for rapid testing solutions are prominent growth factors.Middle East & Africa Point Of Care Infectious Disease Market Report:
The Middle East and Africa region is expected to grow from $0.69 billion in 2023 to $1.80 billion by 2033, driven by increasing healthcare expenditure and the urgent need for effective disease management.Request a custom research report for industry.
Point Of Care Infectious Disease Market Analysis By Test Type
Global Point-of-Care Infectious Disease Market, By Test Type Market Analysis (2023 - 2033)
The market segmentation by test type shows significant differentiation in performance. Molecular tests, being the most accurate, accounted for $4.67 billion in 2023 and are expected to rise to $12.19 billion by 2033, holding a share of 62.32%. Meanwhile, serological tests are projected to grow from $1.93 billion to $5.02 billion, reflecting their essential role in disease diagnosis.
Point Of Care Infectious Disease Market Analysis By Technology
Global Point-of-Care Infectious Disease Market, By Technology Market Analysis (2023 - 2033)
The technology segment reflects diverse innovations, with immunoassays leading the market with a size of $4.67 billion in 2023, projected to reach $12.19 billion by 2033, constituting 62.32% of the market share. Other technologies such as nucleic acid amplification are also significant contributors.
Point Of Care Infectious Disease Market Analysis By Application
Global Point-of-Care Infectious Disease Market, By Application Market Analysis (2023 - 2033)
Applications range across various infectious diseases, and HIV testing shows the largest market size, expected to grow from $3.86 billion in 2023 to $10.07 billion by 2033. Tuberculosis testing and hepatitis testing also contribute significantly to the market landscape.
Point Of Care Infectious Disease Market Analysis By End User
Global Point-of-Care Infectious Disease Market, By End User Market Analysis (2023 - 2033)
Hospitals emerge as the primary end-user segment, with growth anticipated from $3.86 billion to $10.07 billion. Clinics and home care are also gaining traction, reflecting a shift towards decentralized diagnostic approaches.
Point Of Care Infectious Disease Market Analysis By Region
Global Point-of-Care Infectious Disease Market, By Region Market Analysis (2023 - 2033)
The regional analysis identifies North America, Europe, and Asia-Pacific as leading markets, with substantial contributions to overall growth. Each region's unique needs drive demand for specific diagnostic solutions.
Point Of Care Infectious Disease Market Trends and Future Forecast
Request a custom research report for industry.
Global Market Leaders and Top Companies in Point Of Care Infectious Disease Industry
Roche Diagnostics:
A global leader in in-vitro diagnostics, Roche offers a wide range of POC infectious disease testing solutions, integrating innovative technologies.Abbott Laboratories:
Abbott is renowned for its cutting-edge diagnostic tools and has significantly contributed to the POC market, especially in molecular diagnostics.Siemens Healthineers:
Specializing in medical technology, Siemens Healthineers provides advanced POC testing instruments and solutions focusing on infectious diseases.We're grateful to work with incredible clients.
